Efficacy of different nitric oxide-based strategies in preventing experimental cerebral malaria by Plasmodium berghei ANKA.
Low nitric oxide (NO) bioavailability plays a role in the pathogenesis of human as well as of experimental cerebral malaria (ECM) caused by Plasmodium berghei ANKA (PbA). ECM is partially prevented by administration of the NO-donor dipropylenetriamine NONOate (DPTA-NO) at high concentration (1 mg/mo...
Main Authors: | Yuri C Martins, Graziela M Zanini, John A Frangos, Leonardo J M Carvalho |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3278462?pdf=render |
Similar Items
-
Plasmodium Berghei ANKA Infection in ICR Mice as a Model of Cerebral Malaria
by: F Othman, et al.
Published: (2012-12-01) -
<it>In vitro </it>culture of <it>Plasmodium berghei</it>-ANKA maintains infectivity of mouse erythrocytes inducing cerebral malaria
by: Jambou Ronan, et al.
Published: (2011-11-01) -
Human ApoE2 protects mice against Plasmodium berghei ANKA experimental cerebral malaria
by: Rui Liang, et al.
Published: (2023-12-01) -
Upper gastrointestinal pathophysiology due to mouse malaria Plasmodium berghei ANKA infection
by: Mizuho Shimada, et al.
Published: (2019-03-01) -
Attenuated T Cell Responses Are Associated With the Blockade of Cerebral Malaria Development by YOP1-Deficient Plasmodium berghei ANKA
by: Lei Hai, et al.
Published: (2021-05-01)